Friday 6 November 2026
Export GRDN’s income statement to Excel — free account
Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
39.72
2.37
−5.63%
Follow GRDN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
26.76% | 26.83% | 30.14% | 31.47% | |
| 13.42% | 13.95% | 16.48% | 16.96% | ||
ROIC |
29.83% | 28.86% | 31.82% | 36.76% | |
Return on Tangible Assets |
42.27% | 40.43% | 41.94% | 43.18% | |
Average Days of Receivables |
25.60 | 28.00 | 25.88 | 26.97 | |
Free Cash Flow per Share |
1.29 | 1.11 | 1.26 | 0.00 | |
Free Cash Flow |
80.71 | 70.28 | 79.79 | 114.06 | |
Capital Expenditures |
(19.54) | (18.49) | (19.07) | — | |
| Other line items | |||||
Cash ROIC |
28.46% | 23.64% | 22.96% | 28.56% | |
Accounts Receivable Turnover |
14.58 | 13.93 | 14.79 | 13.63 | |
Accounts Payable Turnover |
10.57 | 10.95 | 10.76 | 9.11 | |
Inventory Turnover |
27.55 | 25.42 | 24.25 | 21.54 | |
Average Days of Payables |
36.69 | 34.41 | 34.44 | 40.80 | |
Days of Inventory on Hand |
13.69 | 14.95 | 16.05 | 18.43 | |
Tax Rate |
(0.33) | (0.32) | (0.31) | (0.28) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.19% | 15.61% | 15.79% | 15.99% | |
Share Based Compensation of Revenue |
0.96% | 0.81% | 0.70% | 0.59% | |
Interest Coverage |
109.32 | 119.22 | 135.40 | 145.28 | |
Operating CF/Net income |
2.04 | 1.67 | 1.50 | 1.53 | |
Depreciation/Fixed assets |
0.40 | 0.41 | 0.41 | 0.41 | |
Capex/Depreciation |
(0.88) | (0.80) | (0.82) | 0.00 | |
Revenue per Share |
23.22 | 22.99 | 23.11 | 0.00 | |
Operating CF per Share |
1.61 | 1.40 | 1.56 | 0.00 | |
Capex per Share |
(0.31) | (0.29) | (0.30) | — | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026